RenalSense is building a Realtime Diagnostic Platform for Acute Kidney Injury (AKI) in Critical Care: Detection, Prevention, Management
Business Model:
Revenue: $0
Employees: 11-50
Address: Hamarpe 3
City: Jerusalem
State: jerusalem district
Zip: 9145101
Country: IL
While prevention of kidney injury is highly dependent on early detection of potential risk, the industry has no solutions to address this need. Conventional products and protocols can only report kidney damage after it exists - not prevent it. The growing unmet need for early detection and prevention of risk and for the tools to improve the management of AKI patients in critical care have established the necessity of realtime renal diagnostics solutions. RenalSense&s;s unique products will set new clinical gold standards, improve outcomes and reduce the cost of care.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2019 | Grant | 1 | $825.8k |
Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority |
11/2021 | Series A | 1 | $14M |
BlueRed Partners BlueRed Partners |
5/2019 | Grant | $828k |
Israeli Minstry of Economy and Industry Israel Innovation Authority |
5/2019 | Grant | 1 | $825.8k |
Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority Israel Innovation Authority |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|